LENZ Therapeutics, Inc. Common Stock

LENZNASDAQ • USD
ThemeBiotech - Drug Development›Clinical-Stage Platforms
7.01 USD
↘ 0.19 (2.64%)AT CLOSE (11:59 AM EDT)
7.01
↗ 0.00 (0.01%)
POST MARKET (AS OF 07:51 PM EDT)
Post Market
AS OF 07:51 PM EDT
7.01
↗ 0.00 (0.01%)
🔴Market: CLOSED
Open?$7.19
High?$7.36
Low?$6.92
Prev. Close?$7.20
Volume?494.9K
Avg. Volume?859.9K
VWAP?$7.09
Rel. Volume?0.58x
Bid / Ask
Bid?$6.00 × 100
Ask?$7.93 × 100
Spread?$1.93
Midpoint?$6.97
Valuation & Ratios
Market Cap?225.8M
Shares Out?31.4M
Float?18.2M
Float %?58.2%
P/E Ratio?N/A
P/B Ratio?0.92
EPS?-$3.47
Dividend?0.00%
Ex-Dividend?N/A

Shares of LENZ Therapeutics, Inc. Common Stock (LENZ) are trading at $7.01. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place LENZ at a fair price relative to peers.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
Themes
Biotech - Drug Development›Clinical-Stage PlatformsLongevity & Aging›Age-Related Therapeutics
Employees
152
Market Cap
219.8M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.lenz-tx.com
Listed
2024-03-22
Address
201 LOMAS SANTA FE DRIVE, SUITE 300
SOLANA BEACH, CA 92075
Phone: 858-925-7000
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
85
Momentum?
18
Short Sent.?
10
Piotroski F-Score?0/9Weak
Altman Z-Score?3.53Safe
Confidence?40%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?60.91%Squeeze Risk
Short Interest?11.1M
Days to Cover?11.0
Free Float18.2M
Avg Daily Volume1.0M
Settlement Date2026-05-15
Financial Health
Current Ratio?10.40Strong
Quick Ratio?10.26Strong
Cash Ratio?0.96Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.92CHEAP▾
P/S?
Peers
100
S&P
7
10.76HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.7CHEAP▾
EV/Sales?
Peers
100
S&P
12
9.58HIGH▾
Returns & Efficiency
ROE?
S&P
3
-44.2%WEAK▾
ROA?
S&P
3
-40.0%WEAK▾
Cash Flow & Enterprise
FCF?$-87438000
Enterprise Value?$201.0M
Fundamentals ratios updated end of day
MarketsMoversWatchlist